IFN-γ is produced by T cells upon binding to cancer cells and promotes antitumor immune responses via a variety of mechanisms, including increased expression of tumor-associated antigens (TAA), recruitment and activation of additional immune cells, and promotion of apoptosis of tumor cells [54]. This evidence concerns the gene IFNG and neoplasm.